US 12202832
Heterocyclic compounds having a calcium-sensing receptor antagonistic activity
granted A61KA61K31/4184A61K31/519
Quick answer
US patent 12202832 (Heterocyclic compounds having a calcium-sensing receptor antagonistic activity) held by Takeda Pharmaceutical Company Limited expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jan 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/4184, A61K31/519, A61K47/38, A61K9/2013